Literature DB >> 16470323

Atherothrombosis in acute coronary syndromes: mechanisms, markers, and mediators of vulnerability.

Eric J Wasserman1, Neal M Shipley.   

Abstract

We review the concept of atherothrombosis and the critically important role of inflammation in the development of acute coronary syndromes (ACS). Inflammation is now known to be a major driving force underlying the initiation of coronary plaques, their unstable progression, and eventual disruption, and it also contributes significantly to thrombotic complications that occur in ACS. In addition, we discuss the various local mediators and systemic markers that are involved in the inflammatory process, and review the concepts of 'vulnerable plaque,' 'vulnerable blood,' 'vulnerable myocardium,' and the 'vulnerable patient' who is at increased risk for ACS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16470323

Source DB:  PubMed          Journal:  Mt Sinai J Med        ISSN: 0027-2507


  7 in total

Review 1.  Antiplatelet therapy for atherothrombotic disease: how can we improve the outcomes?

Authors:  Martin Moser; Christoph Bode
Journal:  J Thromb Thrombolysis       Date:  2010-08       Impact factor: 2.300

Review 2.  Oral antiplatelet therapy for atherothrombotic disease: overview of current and emerging treatment options.

Authors:  Dan J Fintel
Journal:  Vasc Health Risk Manag       Date:  2012-02-15

3.  Overcoming limitations of current antiplatelet drugs: a concerted effort for more profitable strategies of intervention.

Authors:  Matteo Nicola Dario Di Minno; Anna Guida; Marina Camera; Susanna Colli; Giovanni Di Minno; Elena Tremoli
Journal:  Ann Med       Date:  2011-08-05       Impact factor: 4.709

4.  Efficacy and safety of Guhong injection for treating coronary microvascular disease: study protocol for a randomized controlled trial.

Authors:  Zhuang Jieqin; Liu Shuling; Cai Hairong; Dai Xingzhen; Chen Yanhong; Jin Zilin; Chen Bojun
Journal:  Trials       Date:  2020-01-13       Impact factor: 2.279

5.  Proteomic Biomarkers of Atherosclerosis.

Authors:  F Vivanco; L R Padial; V M Darde; F de la Cuesta; G Alvarez-Llamas; Natacha Diaz-Prieto; M G Barderas
Journal:  Biomark Insights       Date:  2008-03-12

Review 6.  Inhibitory effects and mechanisms of luteolin on proliferation and migration of vascular smooth muscle cells.

Authors:  Dehua Jiang; Dongye Li; Wanling Wu
Journal:  Nutrients       Date:  2013-05-17       Impact factor: 5.717

7.  Plasma granzyme B in ST elevation myocardial infarction versus non-ST elevation acute coronary syndrome: comparisons with IL-18 and fractalkine.

Authors:  Hala O El-Mesallamy; Nadia M Hamdy; Adel K El-Etriby; Eman F Wasfey
Journal:  Mediators Inflamm       Date:  2013-11-06       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.